Cargando…
Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
Serpentine supravenous hyperpigmentation (SSH) is a rare vasculo-cutaneous entity that has been associated with peripheral infusion of chemotherapy agents, in particular 5-FU(1)(-)(3), but also seen with docetaxel(4)(,)(5), fotemustine(6), and vinorelbine(7). It consists of a marked hyperpigmentatio...
Autores principales: | Lancman, Guido, Steinberg, Amir, Gabrilove, Janice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018244/ https://www.ncbi.nlm.nih.gov/pubmed/29951170 |
Ejemplares similares
-
Serpentine supravenous hyperpigmentation
por: Jamalpur, Indirakshi, et al.
Publicado: (2017) -
Irinotecan-Induced Serpentine Supravenous Hyper-Pigmentation
por: Gaurav, Vishal, et al.
Publicado: (2022) -
Persistent docetaxel-induced supravenous erythematous eruption
por: Fernandes, Karina de Almeida Pinto, et al.
Publicado: (2015) -
DLBCL 1L—What to Expect beyond R-CHOP?
por: Stegemann, Maike, et al.
Publicado: (2022) -
Impact of rituximab on COVID-19 outcomes
por: Levavi, Hannah, et al.
Publicado: (2021)